Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3482-7
Abstract: Unmanipulated haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) has been an established treatment to cure high-risk leukemia/lymphoma. Relapse is the main cause of treatment failure for patients with relapsed/refractory disease or with very high-risk gene… read more here.
Keywords: risk; high risk; pbsct; relapse ... See more keywords
Improved outcomes using unmanipulated haploidentical hematopoietic stem cells combined with third‐party umbilical cord blood transplantation for non‐malignant diseases in children: The experience of a single center
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Transplantation"
DOI: 10.1111/petr.13995
Abstract: Unmanipulated haploid HSCT for SAA has resulted in improved outcomes over recent years. However, studies related to unmanipulated haploid HSCs combined with tp‐UCB transplantation for other types of NMD are rare. Accordingly, we present the… read more here.
Keywords: unmanipulated haploid; outcomes using; using unmanipulated; improved outcomes ... See more keywords